The Pharmaceutical Journal
Vol 280 No 7494 p329
22 March 2008

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Inhaled TB vaccine shows promise

A dry powder form of the Bacillus Calmette-Guérin (BCG) vaccine that can be delivered via an inhaler was as effective as the injectable vaccine when tested in guinea pigs (PNAS Early Edition, 14 March 2008).

Lead researcher Tony Hickey, of the University of North Carolina school of pharmacy, said: “This vaccine does not need to be refrigerated. It also doesn’t require needles, syringes and water like the injectable vaccine, and administering it is as easy as breathing in, making it ideal for use in developing countries.”